ClinConnect ClinConnect Logo
Search / Trial NCT06339827

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Launched by IRA WINER · Mar 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The ASk Questions in GYnecologic Oncology (ASQ-GYO) clinical trial is studying a special tool called the ASQ-GYO question prompt list. This tool is designed to help patients with gynecologic cancers—like ovarian, endometrial, cervical, vulvar, and vaginal cancer, as well as a condition called Gestational Trophoblastic Disease—feel more confident and informed during their first visits with a gynecologic oncologist. The trial will compare how well this tool works in helping patients understand their situation, reduce anxiety, build trust with their doctors, and gain knowledge about their health, compared to usual care without this tool.

To participate in the trial, you need to be at least 18 years old, be able to understand English, and have a biopsy confirming a gynecologic cancer diagnosis or have concerning test results indicating a possible cancer diagnosis without having seen a gynecologic oncologist yet. Unfortunately, if you only have a diagnosis that shows early changes (called dysplasia) or if your tests suggest a non-cancer issue, you won't be eligible. If you join the study, you can expect to use the question prompt list during your visit, which may help you ask important questions and feel more at ease while discussing your health with your doctor. The trial is currently recruiting participants, and everyone's input can help improve care for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 years of age
  • Understands spoken and written English
  • Able to consent to study participation
  • Biopsy confirmed gynecologic cancer diagnosis (ovarian, endometrial, cervical, vulvar, or vaginal cancer or Gestational Trophoblastic Disease) OR have imaging and/or laboratory findings highly concerning for a cancer diagnosis and have not seen a Gynecologic Oncologist
  • Exclusion Criteria:
  • pathologic diagnosis of dysplasia only (cervical, vulvar, or endometrial)
  • History and/or imaging/laboratory findings more indicative of a non-cancer diagnosis
  • Previous treatment discussion with a Gynecologic Oncologist

About Ira Winer

Ira Winer is a distinguished clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on fostering collaboration among healthcare professionals and researchers, Ira Winer emphasizes rigorous trial design and adherence to ethical standards. The organization is committed to conducting high-quality clinical trials that contribute valuable insights to the medical community, ultimately aiming to enhance treatment options and improve the quality of life for patients.

Locations

Detroit, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Ira Winer, MD PhD

Principal Investigator

Barbara Ann Karmanos Cancer Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported